Articles
PDgrastim®
- Comparing efficacy and side effects of Pd-Grastim and Neupogen for prevention of neutropenia after chemotherapy in children
- Evaluation of efficacy and side effects of FILGRASTIM versus PD-Grastim in prevention of neutropenia in patients with neuroblastoma under treatment with OPEC chemotherapy protocol – A Comparative Study
- Effects of Erythropoietin and GCSF on Traumatic Osteonecrosis of the Femoral Head in Rabbits
- Effects of Stem Cells and Granulocyte Colony Stimulating Factor on Reperfusion Injury
- Efficient Process Development of Recombinant Human Granulocyte Colony-Stimulating Factor (rh-GCSF) Production in Escherichia coli
- Prevention and Control of Infections in Patients with Severe Congenital Neutropenia; A Follow up Study
- Therapeutic Outcomes of Transplanting Autologous Granulocyte Colony-stimulating Factor-mobilised Peripheral Mononuclear Cells in Diabetic Patients with Critical Limb Ischaemia
- An efficient purification method for high recovery of Recombinant Human Granulocyte Colony Stimulating Factor from recombinant E.coli
- G-CSF Administration Attenuates Brain Injury in Rats Following Carbon Monoxide Poisoning via Different Mechanisms
- Proteomics screening of molecular targets of granulocyte colony stimulating factor in the mouse brain and PC12 cell line
- The Effect of Granulocyte Colony Stimulating Factor Administration on Preterm Infant with Neutropenia and Clinical Sepsis A Randomized Clinical Trial
- The Structural Characterization of Recombinant Human Granulocyte Colony Stimulating Factor
- (CD34)
Pegaferon®
- Pegaferon® – Safety and Ef cacy of Locally Manufactured Pegylated Interferon in Hepatitis C Patients
- Pegaferon® – Pegaferon in hepatitis C Results of a Multicenter Study
- Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1
- Pegaferon® – Locally Produced Peginterferon As An Opportunity to
- Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C
- Treatment Outcome in Chronic Hepatitis C Infection A Four Years Survey Among Iranian Patients
PDferon®
- PDferon® – Successful interferon desensitization in a patient with
- PDferon® – Preliminary Report of Interferon α2b in Combination with Ribavirin for 48 Weeks for Treatment of Iranian Patients with Chronic Hepatitis C
- PDferon® – Interferon –alpha 2b (PDferon B®) in Treatment of HBeAgnegative
- PDferon® – Efficacy and safety of Interferon-alpha (PDferon B®)
- Clinical outcome of interferon and ribavirin combination treatment in hepatitis C virus infected patients with congenital bleeding disorders in Iran
- Combination therapy with interferon and ribavirin for chronic hepatitis C infection in beta-thalassaemia major
- Combination_Therapy_of_Interferon-alpha (PDferon B®) and Ribavirin for Chronic Hepatitis C
- Conventional Versus Pegylated Interferons in Treatment of HCV patients
- EFFICACY AND SAFETY OF COMBINATION THERAPY OF INTERFERON-ALPHA 2B PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C
- Efficacy of triple therapy with interferon alpha-2b, ribavirin and amantadine in the treatment of naïve patients with chronic hepatitis C
- Hepatitis B virus DNA level as predictor of response to therapy with interferon-alpha-2b (PDferon) in chronic hepatitis B infection
- Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemialymphoma (ATL)
- Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b
PDpoetin®
- PDpoietin in Comparison With Eprex in Treatment of Anemic
- PDpoetin immunogenicity compared with Eprex ,in patients undergoing maintenance hemodialysis
- Safety and efficacy of PDpoetin for management of anemia in patients with end stage renal disease on maintenance hemodialysis results from a phase IV clinical trial
- Hemoglobin and Hematocrit Rise in End-Stage Renal Disease (ESRD) with PDpoetin Results of a Phase Ш, Multicenter Clinical Trial
- Beneficial Erythropoietic Effects of Recombinant Human Erythropoietin in Very Low‑Birth Weight Infants A Single‑Center Randomized Double‑Blinded Placebo‑Controlled Trial
- Does High Dose Erythropoietin administration reduce ischemic stroke complications
- Effect of Erythropoietin on Kidney Allograft Survival Early Use After Transplantation
- Effects of Erythropoietin and GCSF on Traumatic Osteonecrosis of the Femoral Head in Rabbits
- Erythropoietin Reduces Post-PCI Arrhythmias in Patients With ST-elevation Myocardial Infarction
- Neuroprotective Effects of Erythropoietin in Acute Ischemic Stroke
- Protective Role of Recombinant Human Erythropoietin in Kidney and Lung Injury Following Renal Bilateral Ischemia‑Reperfusion in Rat Model
- The Ovario-Protective Effect of Erythropoietin against Oxidative Damage Associated with Reperfusion Following Ovarian Torsion in Rat
- Erythropoietin plus Methylprednisolone or Methylprednisolone in the Treatment of Acute Spinal Cord Injury a Preliminary Report
- Human Erythropoietin Effect in Postoperative Visual Loss Following Spine Surgery A Case Report
- Recombinant human erythropoietin reduces plasminogen activator inhibitor and ameliorates pro-inflammatory responses following trauma
- The efficacy of erythropoietin mouthwash in prevention of oral mucositis in patients undergoing autologous hematopoietic SCT a double-blind, randomized, placebo controlled
- Effect of recombinant erythropoietin in serum paraoxonase activity level,Total antioxidant and lipid peroxidation in Rat.